Sponsors

The Department of Health and Social Care says the NHS will move from a ‘cheapest-first’ to a ‘patient-first’ approach to purchasing medical technology, as it aims to cut waiting lists and save money in the long term.

More....

Event Preview

IBMS Congress

IBMS Congress is an important forum for progressing professional skills and knowledge, supporting career development and promoting the profession. Learn from the leading voices in biomedical science and network with professionals across the field.  The full scientific programme will feature Cellular Pathology, Clinical Chemistry, Cytopathology, Education and Training, Haematology, Immunology,...

See selected highlights

Features

Long COVID: could plasma viscosity detect inflammatory proteins?

David Manuel, David Norcliffe and Bernie Benson look at the prevalence of, and literature around, long COVID since the pandemic and consider measuring plasma viscosity as a diagnostic tool.

Reimagining newborn screening: the future of population health

As new technologies emerge, integrated, automated genomic workflows are set to revolutionise newborn screening. Here, Madhuri Hegde considers the transformative potential of these new advances, along with the ethical and policy frameworks required for responsible implementation.

Products

Eppendorf introduces next generation mechanical pipettes

Life sciences firm Eppendorf has announced the commercial launch of the Eppendorf Research 3 neo range of pipettes, designed to deliver accurate and precise results for accelerated volume selection, and optimised ergonomics.

An automated solution for urine specimen aliquoting

Microbiology laboratory and automation firm Copan has launched UriVerse, a state-of-the-art, fully automated system that transforms the pre-analytical handling of urine specimens by automating key manual steps.

POCT advances from Anbio Biotechnology

In response to recent outbreaks of Chikungunya fever, Anbio Biotechnology has announced the launch of its Chikungunya IgM/IgG Rapid Test, offering clinicians and public health authorities a fast, accessible diagnostic tool at the point of care. The company also has a new PCR system, for quicker POC results.

Agilent expands the Dako Omnis family

Agilent Technologies has announced the introduction of its Dako Omnis family of automated immunohistochemistry and in situ hybridisation instruments with three new models - Agilent Dako Omnis 110, 165, and 165 Duo - designed to meet the evolving needs of pathology laboratories of all sizes.

Latest Issues

Diagnostics North East Conference 2025

The Catalyst, Newcastle
3 October

Delivering POCT: Diagnostics in the Community

Manchester Conference Centre
8 October

BAC Annual Scientific Meeting 2025

Online
20 November, 2025